187 related articles for article (PubMed ID: 32183748)
1. A convolutional neural network-based system to classify patients using FDG PET/CT examinations.
Kawauchi K; Furuya S; Hirata K; Katoh C; Manabe O; Kobayashi K; Watanabe S; Shiga T
BMC Cancer; 2020 Mar; 20(1):227. PubMed ID: 32183748
[TBL] [Abstract][Full Text] [Related]
2. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O
Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346
[TBL] [Abstract][Full Text] [Related]
3.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
4. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [
Aoki H; Miyazaki Y; Anzai T; Yokoyama K; Tsuchiya J; Shirai T; Shibata S; Sakakibara R; Mitsumura T; Honda T; Furusawa H; Okamoto T; Tateishi T; Tamaoka M; Yamamoto M; Takahashi K; Tateishi U; Yamaguchi T
Eur Radiol; 2024 Jan; 34(1):374-383. PubMed ID: 37535157
[TBL] [Abstract][Full Text] [Related]
5. A convolutional neural network-based system to prevent patient misidentification in FDG-PET examinations.
Kawauchi K; Hirata K; Katoh C; Ichikawa S; Manabe O; Kobayashi K; Watanabe S; Furuya S; Shiga T
Sci Rep; 2019 May; 9(1):7192. PubMed ID: 31076620
[TBL] [Abstract][Full Text] [Related]
6. Convolutional Neural Networks in Predicting Nodal and Distant Metastatic Potential of Newly Diagnosed Non-Small Cell Lung Cancer on FDG PET Images.
Tau N; Stundzia A; Yasufuku K; Hussey D; Metser U
AJR Am J Roentgenol; 2020 Jul; 215(1):192-197. PubMed ID: 32348182
[No Abstract] [Full Text] [Related]
7. Generation of PET Attenuation Map for Whole-Body Time-of-Flight
Hwang D; Kang SK; Kim KY; Seo S; Paeng JC; Lee DS; Lee JS
J Nucl Med; 2019 Aug; 60(8):1183-1189. PubMed ID: 30683763
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study.
Shaish H; Mutasa S; Makkar J; Chang P; Schwartz L; Ahmed F
AJR Am J Roentgenol; 2019 Feb; 212(2):238-244. PubMed ID: 30540209
[TBL] [Abstract][Full Text] [Related]
9. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
10. An artificial intelligence-driven image quality assessment system for whole-body [
Qi C; Wang S; Yu H; Zhang Y; Hu P; Tan H; Shi Y; Shi H
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1318-1328. PubMed ID: 36529840
[TBL] [Abstract][Full Text] [Related]
11. Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.
Eubank WB; Mankoff DA; Schmiedl UP; Winter TC; Fisher ER; Olshen AB; Graham MM; Eary JF
AJR Am J Roentgenol; 1998 Oct; 171(4):1103-10. PubMed ID: 9763005
[TBL] [Abstract][Full Text] [Related]
12. PET/CT for Head and Neck Squamous Cell Carcinoma: Should We Routinely Include the Head and Abdomen?
Yankevich U; Hughes MA; Rath TJ; Fakhran S; Alhilahi LM; Seungwon KW; Branstetter BF
AJR Am J Roentgenol; 2017 Apr; 208(4):844-848. PubMed ID: 28177644
[TBL] [Abstract][Full Text] [Related]
13. The OCDA-Net: a 3D convolutional neural network-based system for classification and staging of ovarian cancer patients using [
Sadeghi MH; Sina S; Alavi M; Giammarile F
Ann Nucl Med; 2023 Dec; 37(12):645-654. PubMed ID: 37768493
[TBL] [Abstract][Full Text] [Related]
14. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
15. Sequential
Pietrzak A; Kazmierska J; Cholewinski W
Hell J Nucl Med; 2017; 20 Suppl():80-92. PubMed ID: 29324917
[TBL] [Abstract][Full Text] [Related]
16. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
[TBL] [Abstract][Full Text] [Related]
17. Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT.
Kirienko M; Sollini M; Silvestri G; Mognetti S; Voulaz E; Antunovic L; Rossi A; Antiga L; Chiti A
Contrast Media Mol Imaging; 2018; 2018():1382309. PubMed ID: 30510492
[TBL] [Abstract][Full Text] [Related]
18.
Han EJ; O JH; Yoo IR; Kim YS; Kim MS; Kang JH; Choi WH
Hell J Nucl Med; 2017; 20(2):134-140. PubMed ID: 28697190
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
